Summit Health

atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors

Retrieved on: 
Giovedì, Maggio 23, 2024
Allergan, Allscripts, Rachel Haurwitz, University, Therapy, Drug development, Jennerex, Trevena Inc, Adverum Biotechnologies, Cornell University, Summit Health, Laurent, Pharmaceutical industry

NEW YORK and BERLIN, May 23, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced the appointment of Scott Braunstein, M.D., and Laurent Fischer, M.D., as independent directors of atai’s supervisory board (“Board”) subject to applicable legal requirements.

Key Points: 
  • NEW YORK and BERLIN, May 23, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced the appointment of Scott Braunstein, M.D., and Laurent Fischer, M.D., as independent directors of atai’s supervisory board (“Board”) subject to applicable legal requirements.
  • He is an operating partner at Aisling Capital and serves on the Board of Directors at both Caribou Biosciences, Inc. and Trevena Inc.
  • Laurent Fischer, M.D., is the CEO and President of Adverum Biotechnologies and serves on the Board of Directors at Mirum Pharmaceuticals, Inc., Lycia Therapeutics and Teal.
  • Christian Angermayer, Founder and Chairman of atai, said: “I am thrilled to welcome Scott and Laurent to atai’s Board.

Connecticut Magazine Honors 39 Physicians from Summit Health and Starling Physicians

Retrieved on: 
Mercoledì, Maggio 1, 2024
General Health, Health, Practice Management, Other Health, Connecticut Magazine, Physician, Summit Health, MD, Patient, Nursing

Thirty-nine physicians from Summit Health and Starling Physicians were named as 2024 “Top Doctors” by Connecticut Magazine.

Key Points: 
  • Thirty-nine physicians from Summit Health and Starling Physicians were named as 2024 “Top Doctors” by Connecticut Magazine.
  • The physicians are nominated by their colleagues to earn Top Doctor recognition through the national Castle Connolly’s annual peer doctor-survey.
  • Summit Health also has one doctor listed as a Rising Star in the May issue.
  • “At Summit Health and Starling Physicians, our team of physicians works tirelessly to provide exceptional care for patients throughout their lifetime,” says Adam Barrison, MD, Chief Physician Executive at Summit Health.

VillageMD Welcomes Jim Murray as President & Chief Operating Officer

Retrieved on: 
Mercoledì, Aprile 10, 2024
Nursing, Hospitals, Fitness & Nutrition, Telemedicine, Virtual Medicine, Health Insurance, Practice Management, Alternative Medicine, Managed Care, General Health, Health, Humana, Magellan Health, Tricare, Summit Health, Patient, Medicare, CityMD, Ferdinand Magellan

VillageMD announced today that Jim Murray has joined the organization as its president & chief operating officer (COO) effective April 1.

Key Points: 
  • VillageMD announced today that Jim Murray has joined the organization as its president & chief operating officer (COO) effective April 1.
  • In this role, Murray will lead operations across the entire VillageMD enterprise, including for its three key business units, Village Medical, Summit Health and CityMD.
  • Prior, Murray was the president and COO of behavioral health leader Magellan Health, which Centene acquired in 2022.
  • Prior to Centene and Magellan, Murray held executive roles at Humana for 28 years, most recently as executive vice president and COO.

One Biosciences Welcomes Dr. Scott Braunstein and Dr. Vincent Miller to its Board of Directors

Retrieved on: 
Mercoledì, Marzo 27, 2024
Constellation, Single-cell analysis, Lung cancer, EGFR, Health, Biotechnology, Rachel Haurwitz, New Jersey Medical School, Foundation Medicine, Cornell University, University, Knowledge, American Cancer Society, Research, Esperion Therapeutics, Cancer, A.I, Medicine, Summit Health, Esperies, Therapy, Drug development, Partner, MorphoSys, JPMorgan Chase, Thomas Jefferson University Hospital

to identify a new generation of precision medicine targets and develop new treatments, today announced the appointments of Dr. Scott Braunstein, and Dr. Vincent Miller, to its Board of Directors.

Key Points: 
  • to identify a new generation of precision medicine targets and develop new treatments, today announced the appointments of Dr. Scott Braunstein, and Dr. Vincent Miller, to its Board of Directors.
  • Our proprietary discovery engine has identified its first promising targets, and we are preparing to start drug development activities in 2025.
  • Bolstering our Board with such seasoned leaders will be a key factor to success.”
    Dr. Scott Braunstein brings over 30 years of knowledge and experience gained in the biotechnology, pharmaceutical, and biotech portfolio management industries.
  • Dr. Braunstein is currently on the board at Trevena and Caribou Biosciences.

BrainCheck Showcases Latest Innovations at American Medical Group Association Annual Conference

Retrieved on: 
Martedì, Aprile 9, 2024
Diagnosis, AMGA, Conference, Screen, Deficit spending, Risk, Patient, Tablet, American Medical Group Association, MD, D.O, Summit Health, Amnesia, Cognition, Pathology, Dementia, FDA, Medical device

AUSTIN, Texas, April 9, 2024 /PRNewswire/ -- BrainCheck, Inc., a digital health innovator delivering next-generation technology into the growing digital cognitive assessment market, will showcase its comprehensive cognitive assessment platform, including its latest innovation, Screen™, in booth #202 at the American Medical Group Association (AMGA) Annual Conference from April 9-12 in Orlando, FL. Chelsea Dugan, Vice President of Marketing, and members of the BrainCheck team will attend the event to share BrainCheck's latest technology with medical groups and health system executives nationwide.

Key Points: 
  • Chelsea Dugan, Vice President of Marketing, and members of the BrainCheck team will attend the event to share BrainCheck's latest technology with medical groups and health system executives nationwide.
  • Expertly designed with patients in mind, BrainCheck's clinically proven platform offers a comprehensive digital solution, streamlining screening, assessment, care planning, and monitoring.
  • "BrainCheck's technology has transformed the way we assess patients' cognitive health in our practice," said Eric R. Penniman, D.O., Executive Medical Director, Summit Medical Group.
  • Early detection of cognitive impairment is key to unlocking opportunities to preserve patients' brain health," said Reza Ghomi, MD, MSE, neuropsychiatrist and Chief Medical Officer at BrainCheck.

Summit Health Names Timothy Reish, M.D., Chair of Orthopedics and Sports Medicine, Pain Management and Podiatry

Retrieved on: 
Martedì, Aprile 2, 2024
Health, Surgery, Practice Management, Physical Therapy, Other Health, Managed Care, General Health, Knee, Shoulder, Orthopedic surgery, Patient, Franklin Avenue, Research, Pain management, Elbow, Summit Health, Summit, Sports medicine, Dentistry

Timothy Reish, M.D., has been named Chair of Orthopedics and Sports Medicine, Pain Management and Podiatry of Summit Health’s NY South region.

Key Points: 
  • Timothy Reish, M.D., has been named Chair of Orthopedics and Sports Medicine, Pain Management and Podiatry of Summit Health’s NY South region.
  • He has been a practicing Orthopedic Surgeon in New York City for more than 20 years.
  • “We are thrilled that Dr. Reish will be leading three of our key departments that are essential to the health and well-being of our patients throughout their lifetime,” said Christine Masterson, M.D., executive vice president at Summit Health.
  • “I look forward to helping our Orthopedics, and Sports Medicine, Pain Management and Podiatry departments stay at the forefront of healthcare by offering the latest advancements and cutting-edge techniques in the fields of Orthopedics and Sports Medicine, Pain Management and Podiatry,” said Dr. Reish.

Walgreens Boots Alliance Reports Fiscal 2024 First Quarter Results

Retrieved on: 
Giovedì, Gennaio 4, 2024
Retail, Health, Convenience Store, Other Retail, Specialty, General Health, Pharmaceutical, Operating cost, Shield, Pandemic, Acquisition, WBA, Holiday, Risk, COVID-19, Average cost, Growth, Net, GAAP, Security (finance), Summit Health, EPS

On a pro forma basis, the segment's businesses grew sales at a combined rate of 12 percent in the quarter, led by VillageMD and Shields.

Key Points: 
  • On a pro forma basis, the segment's businesses grew sales at a combined rate of 12 percent in the quarter, led by VillageMD and Shields.
  • Adjusted operating loss, which excludes certain costs related to stock compensation expense and amortization of acquired intangible assets, was $96 million compared to $152 million in the year-ago quarter.
  • Adjusted EBITDA loss of $39 million improved by $84 million versus the prior year quarter reflecting growth across all businesses and cost discipline.
  • WBA will hold a conference call to discuss the first quarter results beginning at 8:30 a.m. Eastern time today, January 4, 2024.

BrainCheck Expands First End-to-End Solution for Cognitive Care

Retrieved on: 
Martedì, Ottobre 24, 2023
Summit Health, Alzheimer's disease, University of Washington School of Medicine, National Alzheimer's Project Act, Moca, Trial of the century, AD, Montreal Cognitive Assessment, Health information management, Medicare, Breast Cancer Awareness Month, Data, Deficit spending, D.O, Health, Research, Clinical trial, Dementia, Severity, Tablet, University, MSE, EHR, Patient, Computerize, Montreal, Cholesterol, Medical imaging, Medical device, MD, Index

AUSTIN, Texas, Oct. 24, 2023 /PRNewswire/ -- BrainCheck, Inc. launched the next generation of its comprehensive platform and unveiled its latest innovation, BrainCheck® Screen™, at the Clinical Trials on Alzheimer's Disease (CTAD) conference in Boston, Massachusetts from October 24-27, ahead of National Alzheimer's Awareness Month. New research supporting BrainCheck's comprehensive digital cognitive assessment tool will also be presented at the meeting.

Key Points: 
  • "More than six million Americans have Alzheimer's disease (AD), the most common type of dementia, but unfortunately many remain undiagnosed,i" said Kim Rodriguez, CEO of BrainCheck.
  • "Early diagnosis will help close this gap, and our platform empowers providers to easily access information on patients' cognitive health by offering a unique solution that includes screening, assessment, care planning, and monitoring.
  • The latest version brings cognitive care to the next level, expanding access to our technology from any device or location, in-clinic or remote.
  • The next generation of the BrainCheck platform allows digital cognitive testing on any internet-connected device – including phones, tablets and browsers – regardless of the patient or clinician's location.

VillageMD Announces New Leadership Appointments for Three Services Lines – Summit Health, CityMD and Village Medical

Retrieved on: 
Mercoledì, Ottobre 18, 2023
Alternative Medicine, Health, Other Health, Pharmaceutical, Practice Management, Mental Health, Telemedicine, Virtual Medicine, Managed Care, General Health, Hospitals, Health Technology, Fitness & Nutrition, Health Insurance, Nursing, CityMD, Summit Health, JD, Sutter Health, Population health, United, Artificial intelligence, City, Growth, Physician, Patient, Management

VillageMD announced today three new presidents to lead the three patient-facing services lines of Summit Health, CityMD and Village Medical:

Key Points: 
  • VillageMD announced today three new presidents to lead the three patient-facing services lines of Summit Health, CityMD and Village Medical:
    Rishi Sikka, M.D., will join the organization as president of Village Medical.
  • As president, Dr. Sikka will be responsible for the clinical outcomes of Village Medical, a leading provider of comprehensive and coordinated primary care services.
  • Dr. Sikka has more than 20 years of leadership experience in health systems, value-based care, and digital health.
  • Prior to VillageMD, Dr. Sikka served as president of system enterprises for Sutter Health, managing the responsibilities for ambulatory, population health, non-clinical and health plan businesses.

Promaxo Announces Sale of 20 Systems in the Third Quarter 2023

Retrieved on: 
Lunedì, Ottobre 2, 2023
ASC, IDN, Summit Health, Sale, MRI, Hospital, Rhode Island Hospital, Alpert Medical School, Growth, AI, Robotics, FDA, Urology, Nursing

OAKLAND, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced the sale of 20 systems in the third quarter ending September 30, 2023.

Key Points: 
  • OAKLAND, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced the sale of 20 systems in the third quarter ending September 30, 2023.
  • Promaxo has sold a total of 52 systems through the first nine months of 2023, compared to 13 systems during the same prior year period.
  • The Company has sold a total of 77 systems across 26 states since its commercial launch in the fourth quarter of 2021.
  • “We are happy to announce another quarter of great execution,” said Dr. Amit Vohra, Founder and CEO of Promaxo.